Alexis Kramer

Pharma

Tenpoint reveals positive Phase 3 data for vision drug after Visus merger

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

Alexis Kramer January 10, 2025

Pharma

Drugmakers cut some list prices, shrinking room for rebates in cancer, asthma and diabetes

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

Alexis Kramer January 8, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Alexis Kramer

Tenpoint reveals positive Phase 3 data for vision drug after Visus merger

Drugmakers cut some list prices, shrinking room for rebates in cancer, asthma and diabetes

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe